Your browser doesn't support javascript.
loading
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors.
Falchook, Gerald S; Sachdev, Jasgit; Imedio, Esteban Rodrigo; Kumar, Sanjeev; Mugundu, Ganesh M; Jenkins, Suzanne; Chmielecki, Juliann; Jones, Suzanne; Spigel, David R; Johnson, Melissa.
Afiliação
  • Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA. gerald.falchook@sarahcannon.com.
  • Sachdev J; HonorHealth Research Institute, Scottsdale, AZ, USA.
  • Imedio ER; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Kumar S; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Mugundu GM; Clinical Pharmacology and Quantitative Pharmacology, CPSS, AstraZeneca, Boston, MA, USA.
  • Jenkins S; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Chmielecki J; Translational Medicine, Early Research and Development, AstraZeneca, Boston, MA, USA.
  • Jones S; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Spigel DR; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Johnson M; Tennessee Oncology, Nashville, TN, USA.
Invest New Drugs ; 41(3): 493-502, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37171722
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia / Neoplasias Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia / Neoplasias Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article